Madecassoside

CAS : 34540-22-2

Ref. BP-BP0911

Informations sur le produit

• Nom: Madecassoside
• Synonymes: Asiaticoside A, 6-deoxyhexopyranosyl-(1->4)hexopyranosyl-(1->6)-1-O-(2,3,6,23-tetrahydroxy-28-oxours-12-en-28-yl)hexopyranose, Madecasoside, Redermic, Urs-12-en-28-oic acid, 2,3,6,23-tetrahydroxy-, O-6-deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl-(1→4)-O-β-<smallcap>D</smallcap>-glucopyranosyl-(1→6)-β-<smallcap>D</span>-glucopyranosyl ester, (2α,3β,4α,6β)-, Urs-12-en-28-oic acid, 2,3,6,23-tetrahydroxy-, O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl ester, (2α,3β,4α,6β)-

Description

Madecassoside is a mechanism-based inhibitor of CYP2C19 and CYP3A4, which has antioxidant, anti-inflammatory, anti-apoptosis, wound-healing, and neuroprotective activities, It may have cardioprotective effects in LPS-mediated through inhibition of ERK, p38, and NF-κB activity, it inhibited the pro-inflammatory mediators, including COX-2 expression, PGE2 production, TNF-αand IL-6 levels and the up-regulation anti-inflammatory molecule IL-10.

• Marque: Biopurify

Propriétés chimiques

• Masse moléculaire: 975.132
• Formule: C₄₈H₇₈O₂₀
• Degré de pureté: 95%~99%